<--- Back to Details
First PageDocument Content
Medicine / Tuberculosis treatment / Mycobacterium / National Jewish Health / Isoniazid / Lowenstein–Jensen medium / Pyrazinamide / Infectious disease / Tuberculosis diagnosis / Tuberculosis / Bacteria / Microbiology
Date: 2013-05-23 12:06:51
Medicine
Tuberculosis treatment
Mycobacterium
National Jewish Health
Isoniazid
Lowenstein–Jensen medium
Pyrazinamide
Infectious disease
Tuberculosis diagnosis
Tuberculosis
Bacteria
Microbiology

Microsoft Word - IDB 03_10.doc

Add to Reading List

Source URL: healthvermont.gov

Download Document from Source Website

File Size: 71,09 KB

Share Document on Facebook

Similar Documents

Production and proteomic characterisation of purified protein derivative from Mycobacterium avium subsp. paratuberculosis

DocID: 1v7kw - View Document

RESUMO A associação da infecção pelo vírus da imunodeficiência humana (HIV) e Mycobacterium tuberculosis é uma potencial ameaça à Saúde Pública em muitos países do mundo. A presença dos linfócitos T C04 é

DocID: 1uI0q - View Document

Southeast Asian J Trop Med Public Health EVALUATION OF MYCOBACTERIAL INTERSPERSED REPETITIVE UNIT-VARIABLE NUMBER TANDEM REPEAT TYPING TO DISCRIMINATE MYCOBACTERIUM TUBERCULOSIS STRAINS FROM MYANMAR

DocID: 1uedb - View Document

RRA-Mycobacterium, Cardiovascular infection-Switzerland, Netherlands

DocID: 1t0Ut - View Document

Morbidity and Mortality Weekly Report Notes from the Field Mycobacterium chimaera Contamination of Heater-Cooler Devices Used in Cardiac Surgery — United States

DocID: 1sTge - View Document